ICU Medical, Inc. Fundamental Analysis (NASDAQ: ICUI)
ICU Medical, Inc. Fundamental Analysis (NASDAQ: ICUI)
ICU Medical, Inc. (NASDAQ: ICUI) shows weak financial fundamentals with a PE ratio of 152.95, profit margin of 1.39%, and ROE of 1.41%. The company generates $2.2B in annual revenue with weak year-over-year growth of -6.38%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 29.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze ICUI's fundamental strength across five key dimensions:
Efficiency Score
WeakICUI struggles to generate sufficient returns from assets.
Valuation Score
ModerateICUI shows balanced valuation metrics.
Growth Score
WeakICUI faces weak or negative growth trends.
Financial Health Score
ExcellentICUI maintains a strong and stable balance sheet.
Profitability Score
ModerateICUI maintains healthy but balanced margins.
Key Financial Metrics
Is ICUI Expensive or Cheap?
P/E Ratio
ICUI trades at 152.95 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, ICUI's PEG of 0.01 indicates potential undervaluation.
Price to Book
The market values ICU Medical, Inc. at 2.13 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 12.14 times EBITDA. This signals the market has high growth expectations.
How Well Does ICUI Make Money?
Net Profit Margin
For every $100 in sales, ICU Medical, Inc. keeps $1.39 as profit after all expenses.
Operating Margin
Core operations generate 5.04 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $1.41 in profit for every $100 of shareholder equity.
ROA
ICU Medical, Inc. generates $0.76 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
ICU Medical, Inc. produces operating cash flow of $236.31M, showing steady but balanced cash generation.
Free Cash Flow
ICU Medical, Inc. produces free cash flow of $152.79M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $6.11 in free cash annually.
FCF Yield
ICUI converts 3.34% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
152.95
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.007
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.13
vs 25 benchmark
P/S Ratio
Price to sales ratio
2.12
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.59
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.43
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.01
vs 25 benchmark
ROA
Return on assets percentage
0.008
vs 25 benchmark
ROCE
Return on capital employed
0.03
vs 25 benchmark
How ICUI Stacks Against Its Sector Peers
| Metric | ICUI Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 152.95 | 31.19 | Worse (Expensive) |
| ROE | 1.41% | 447.00% | Weak |
| Net Margin | 1.39% | 21601.00% | Weak |
| Debt/Equity | 0.59 | 0.54 | Neutral |
| Current Ratio | 2.43 | 5.66 | Strong Liquidity |
| ROA | 0.76% | -50.00% (disorted) | Weak |
ICUI outperforms its industry in 1 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews ICU Medical, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
48.87%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
-99.29%
Industry Style: Defensive, Growth, Innovation
DecliningFCF CAGR
-31.49%
Industry Style: Defensive, Growth, Innovation
Declining